Alcohol Use DisorderNCT06118346
A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings
A study testing Female-Specific Cognitive Behavioral Therapy (FS-CBT) in people with Alcohol Use Disorder and Risky Health Behavior, run by University of Massachusetts, Worcester at 1 site in United States.
Trial summary
The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Alcohol Use Disorder, Risky Health Behavior
- What is being tested?
- Female-Specific Cognitive Behavioral Therapy (FS-CBT)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 162 participants
- Where
- 1 siteUnited States
- Study dates
- 24 Feb 2023to 30 Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- women aged 18 or older
- Veteran of the U.S. Armed Forces
- Enrolled in healthcare at VA NYHHS;
- AUDIT-C ≥3 plus diagnosis of AUD and/or risky drinking (defined by the National Institute on Alcohol Abuse and Alcoholism as more than 3 drinks on any one day or more than 7 drinks per week) on more detailed screening
- consumed alcohol within 90 days prior to our study's initial eligibility screen.
Who cannot join
- participant is acutely suicidal
- participant has acute psychotic or manic symptoms associated with severe mental illness
- participant is pregnant at initial eligibility screen.
Trial locations and contacts
1 site in 1 country.
United States1 site
VA New York Harbor Healthcare System
New York, New York, 10010
About this study
Official title: A Female-Specific Cognitive Behavioral Therapy Group for Alcohol Use Disorder in VA Primary Care Settings
The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.
Read the detailed description
This is a five year Hybrid Type 1 effectiveness-implementation study. For Aim 1, 162 female Veterans with AUD will be enrolled over 2.5 years in the study at Primary Care and Women's Comprehensive Primary Care Clinics (i.e., the Women's Health Clinic) in the VA New York Harbor Healthcare System (VA NYHHS) (n=162) for a final sample of 140 at 15 month post-baseline (i.e.,12 month post treatment) follow up. The 86% follow up rate is based on Dr. Epstein's prior Randomized Control Trial (RCT) testing FS-CBT for civilian women with AUD on which the current Veteran- Centric FS-CBT group is based. After the research baseline interview, participants will be randomly assigned to either Usual Care (UC, which is Brief Alcohol Counseling +Referral to Substance Use Disorder (SUD) Specialty Care if indicated, all called Brief Alcohol Counselling (BAC), and otherwise also known as Brief Intervention and Referral to treatment (BIRT)) or to the 12 session, rolling entry group Veteran Female Specific CBT for AUD (FS-CBT) held within the VA NYHHS Women's Health Clinic. Participants in both conditions will complete the same baseline (BL), 3-, 9- and 15-months post-BL (i.e., 0-, 6-, \& 12-months after treatment) research assessments. Primary outcome variables will be treatment access (attending least one FS- CBT group session or 1 SUD specialty care session in the FS-CBT condition, and at least 1 SUD specialty care session in the usual UC condition; treatment engagement is defined as number of treatment hours attended in each condition); drinking outcomes (percent drinking days and percent heavy drinking days during and 1 year after the treatment phase). Secondary outcomes include drug use, mental health, social support for abstinence, and health behaviors. For Aim 2, a formative evaluation will be done during the RCT using program process data to track provider interest, patient enrollment rates, reasons for refusal, and treatment adherence.
Using an implementation science framework (Consolidated Framework for Implementation Research, CFIR), the investigators will evaluate implementation barriers and facilitators of FS-CBT in VA PC using qualitative interviews with 20 women Veterans in FS-CBT, 20 in UC, 15 women with AUD who were eligible but did not enroll in the RCT, and 16 providers/stakeholders. The goal of the formative evaluation is to help determine factors at the system, provider, and patient levels that affect the likelihood that FS-CBT will be successfully implemented and sustained in VA Primary Care (PC). The evaluation will allow for more rapid translational gains in terms of intervention uptake and sustainability. The evaluation will include the systematic collection of quantitative RCT process data (e.g., number and % of patient referral opt-outs by Primary Care Providers (PCPs), % of eligible women who enroll, reasons for refusal, number of group sessions completed by Veteran characteristics), and qualitative data via interviews with patient and staff stakeholders. To learn about patient-level barriers/facilitators, study personnel will conduct interviews with 20 female Veterans who were randomized to the FS-CBT condition, and 20 who were randomized to UC: (a) one-half will be drawn from those who completed the full dose (12 sessions in FS-CBT and all treatment recommendations in UC) and the other half from those who dropped out and completed less than the recommended minimal dose. Investigators will sample from participants who significantly reduced their drinking and from those who did not. Investigators will include a diverse sample of Veterans based on age, gender, race/ethnicity, era of military service, and diagnoses (e.g., PTSD). Lastly, study personnel will interview 15 women with AUD who were eligible but did not enroll in the RCT to understand their perceptions of the program and barriers to participation.
The CFIR framework will be used to guide the interview approach. CFIR is a typology of 39 constructs from five main domains that identify factors associated with successful implementation and maintenance of health care innovations: (1) Intervention Characteristics; (2) Inner Setting; (3) Outer Setting; Characteristics of Individuals; (5) Process. If Aim 1 hypotheses are supported, these interviews will help guide subsequent implementation trials of FS-CBT by explaining: (a) barriers and facilitators to participation; perceptions about why FS-CBT is successful at achieving better outcomes for women Veterans with AUD; the barriers and facilitators to high fidelity implementation of FS-CBT; and the sustainability of FS-CBT in the absence of a funded research project and how to achieve this goal; and (b) how FS-CBT should be adjusted to appeal to the subgroup of Veterans. If Aim 1 hypotheses are not supported, the interviews will determine the reasons why (i.e., questions posed to staff and patients will solicit information on barriers associated with delivery of FS-CBT during the RCT, and what modifications to FS-CBT could be made to maximize effectiveness).
- Conditions
- Alcohol Use Disorder, Risky Health Behavior
- Being tested
- Female-Specific Cognitive Behavioral Therapy (FS-CBT), Usual Care
- Medical subject headings
- Alcoholism, Health Risk Behaviors
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Female-Specific Cognitive Behavioral Therapy (FS-CBT)Behavioural
FS-CBT is a unique 12-session weekly group CBT treatment designed for women Veterans with AUD and/or risky drinking, and provides (1) AUD interventions, (2) general female-specific content, (3) female-Veteran content, (4) wellness and self-care, and (5) a novel 24/7 social support for abstinence discussion mobile app.
Usual CareBehavioural
Usual care means that participants will receive brief alcohol counseling and have access to available treatments for AUD at the VA.
| Study group | Role | What they receive |
|---|---|---|
| Female-Specific Cognitive Behavioral Therapy | Experimental | Participants in this arm will receive female-specific cognitive behavioral therapy and usual VA care for alcohol use disorder. Receives: Behavioral: Female-Specific Cognitive Behavioral Therapy (FS-CBT); Behavioral: Usual Care |
| Usual Care | Active comparator | Participants in this arm will receive usual VA care for alcohol use disorder. Receives: Behavioral: Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Alcohol Use Disorders Identification Test (AUDIT)
10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Structured Clinical Interview for DSM Disorders (SCID) Alcohol Use Disorder Module
semi-structured interview that assesses for alcohol use disorder based on the Diagnostic and Statistical Manual for Mental Disorders (DSM)
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Form 90 Timeline Followback (TLFB)
interview used to assess alcohol and drug use over a specific period of time
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Treatment Services Review (TSR)
interview used to assess use of Veterans Affairs and non-Veterans Affairs treatments including Alcohol Use Disorder treatment, physical and mental health treatment, and use of medications
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Electronic Medical Record (EMR)
patient's medical records - review to assess use of Veterans Affairs and non-Veterans Affairs treatments including Alcohol Use Disorder treatment, physical and mental health treatment, and use of medications
Measured: assessed from baseline to 15-months post-baseline follow-up
Secondary outcomes (8)
Outcome Questionnaire-45
self-report questionnaire used to rate symptoms, interpersonal problems, and social role dysfunction
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Posttraumatic Stress Disorder Checklist (PCL)-5 with Life Events Checklist (LEC)-5
combined self-report questionnaire and interview used to measure posttraumatic stress disorder symptoms
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Difficulties in Emotion Regulation Scale (DERS)
self-report questionnaire that assesses emotion regulation
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Coping Strategies Scale (CSS)
self-report questionnaire used to assess use of coping strategies
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Important People Interview (IPI)
interview used to assess social network characteristics
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Sociotropy Autonomy Scale (SAS)
self-report questionnaire used to assess the two personality dimensions of sociotropy and autonomy
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Use of Women2Women mobile application
tracking use of mobile app designed to allow participants randomized to the FS-CBT (female-specific cognitive behavioral therapy) + UC (usual care) to interact with and provide support to one another
Measured: assessed from baseline to 15-months post-baseline follow-up
Self-Care Questionnaire
self-report questionnaire used to assess level of self-care
Measured: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Nov 2023
- Study start24 Feb 2023
- Primary completion15 Jun 2026
- Study completion30 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alcohol Use DisorderStudies of the same condition, open and under way.
- More trials run by University of Massachusetts, WorcesterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 162 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Massachusetts, Worcester
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Responsible party
- Principal investigator, Elizabeth Epstein, University of Massachusetts, Worcester
- Investigators
- Elizabeth E Epstein, PHD, Principal investigator, University of Massachusetts, Worcester
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06118346
- Sponsor's protocol ID
- H00021304
- Other IDs
- 1R01AA028240-01A1
- Status last verified
- May 2026
- First submitted
- 31 May 2023
- Last updated
- 16 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Female-Specific Cognitive Behavioral Therapy Group for Alcohol Use Disorder in VA Primary Care Settings
- ClinicalTrials.gov ID
- NCT06118346
- Acronym / sponsor ID
- H00021304
- Conditions
- Alcohol Use Disorder, Risky Health Behavior
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 162 participants (estimated)
- Lead sponsor
- University of Massachusetts, WorcesterUniversity, hospital or other
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Study start
- 24 Feb 2023 (actual)
- Primary completion
- 15 Jun 2026 (actual)
- Study completion
- 30 Jan 2027 (estimated)
- First posted
- 7 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.
Detailed description
This is a five year Hybrid Type 1 effectiveness-implementation study. For Aim 1, 162 female Veterans with AUD will be enrolled over 2.5 years in the study at Primary Care and Women's Comprehensive Primary Care Clinics (i.e., the Women's Health Clinic) in the VA New York Harbor Healthcare System (VA NYHHS) (n=162) for a final sample of 140 at 15 month post-baseline (i.e.,12 month post treatment) follow up. The 86% follow up rate is based on Dr. Epstein's prior Randomized Control Trial (RCT) testing FS-CBT for civilian women with AUD on which the current Veteran- Centric FS-CBT group is based. After the research baseline interview, participants will be randomly assigned to either Usual Care (UC, which is Brief Alcohol Counseling +Referral to Substance Use Disorder (SUD) Specialty Care if indicated, all called Brief Alcohol Counselling (BAC), and otherwise also known as Brief Intervention and Referral to treatment (BIRT)) or to the 12 session, rolling entry group Veteran Female Specific CBT for AUD (FS-CBT) held within the VA NYHHS Women's Health Clinic. Participants in both conditions will complete the same baseline (BL), 3-, 9- and 15-months post-BL (i.e., 0-, 6-, \& 12-months after treatment) research assessments. Primary outcome variables will be treatment access (attending least one FS- CBT group session or 1 SUD specialty care session in the FS-CBT condition, and at least 1 SUD specialty care session in the usual UC condition; treatment engagement is defined as number of treatment hours attended in each condition); drinking outcomes (percent drinking days and percent heavy drinking days during and 1 year after the treatment phase). Secondary outcomes include drug use, mental health, social support for abstinence, and health behaviors. For Aim 2, a formative evaluation will be done during the RCT using program process data to track provider interest, patient enrollment rates, reasons for refusal, and treatment adherence.
Using an implementation science framework (Consolidated Framework for Implementation Research, CFIR), the investigators will evaluate implementation barriers and facilitators of FS-CBT in VA PC using qualitative interviews with 20 women Veterans in FS-CBT, 20 in UC, 15 women with AUD who were eligible but did not enroll in the RCT, and 16 providers/stakeholders. The goal of the formative evaluation is to help determine factors at the system, provider, and patient levels that affect the likelihood that FS-CBT will be successfully implemented and sustained in VA Primary Care (PC). The evaluation will allow for more rapid translational gains in terms of intervention uptake and sustainability. The evaluation will include the systematic collection of quantitative RCT process data (e.g., number and % of patient referral opt-outs by Primary Care Providers (PCPs), % of eligible women who enroll, reasons for refusal, number of group sessions completed by Veteran characteristics), and qualitative data via interviews with patient and staff stakeholders. To learn about patient-level barriers/facilitators, study personnel will conduct interviews with 20 female Veterans who were randomized to the FS-CBT condition, and 20 who were randomized to UC: (a) one-half will be drawn from those who completed the full dose (12 sessions in FS-CBT and all treatment recommendations in UC) and the other half from those who dropped out and completed less than the recommended minimal dose. Investigators will sample from participants who significantly reduced their drinking and from those who did not. Investigators will include a diverse sample of Veterans based on age, gender, race/ethnicity, era of military service, and diagnoses (e.g., PTSD). Lastly, study personnel will interview 15 women with AUD who were eligible but did not enroll in the RCT to understand their perceptions of the program and barriers to participation.
The CFIR framework will be used to guide the interview approach. CFIR is a typology of 39 constructs from five main domains that identify factors associated with successful implementation and maintenance of health care innovations: (1) Intervention Characteristics; (2) Inner Setting; (3) Outer Setting; Characteristics of Individuals; (5) Process. If Aim 1 hypotheses are supported, these interviews will help guide subsequent implementation trials of FS-CBT by explaining: (a) barriers and facilitators to participation; perceptions about why FS-CBT is successful at achieving better outcomes for women Veterans with AUD; the barriers and facilitators to high fidelity implementation of FS-CBT; and the sustainability of FS-CBT in the absence of a funded research project and how to achieve this goal; and (b) how FS-CBT should be adjusted to appeal to the subgroup of Veterans. If Aim 1 hypotheses are not supported, the interviews will determine the reasons why (i.e., questions posed to staff and patients will solicit information on barriers associated with delivery of FS-CBT during the RCT, and what modifications to FS-CBT could be made to maximize effectiveness).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Female-Specific Cognitive Behavioral Therapy | Experimental | Behavioral: Female-Specific Cognitive Behavioral Therapy (FS-CBT), Behavioral: Usual CareParticipants in this arm will receive female-specific cognitive behavioral therapy and usual VA care for alcohol use disorder. |
| Usual Care | Active comparator | Behavioral: Usual CareParticipants in this arm will receive usual VA care for alcohol use disorder. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- women aged 18 or older
- Veteran of the U.S. Armed Forces
- Enrolled in healthcare at VA NYHHS;
- AUDIT-C ≥3 plus diagnosis of AUD and/or risky drinking (defined by the National Institute on Alcohol Abuse and Alcoholism as more than 3 drinks on any one day or more than 7 drinks per week) on more detailed screening
- consumed alcohol within 90 days prior to our study's initial eligibility screen.
Key exclusion criteria (3 listed)
- participant is acutely suicidal
- participant has acute psychotic or manic symptoms associated with severe mental illness
- participant is pregnant at initial eligibility screen.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Female-Specific Cognitive Behavioral Therapy (FS-CBT)FS-CBT is a unique 12-session weekly group CBT treatment designed for women Veterans with AUD and/or risky drinking, and provides (1) AUD interventions, (2) general female-specific content, (3) female-Veteran content, (4) wellness and self-care, and (5) a novel 24/7 social support for abstinence discussion mobile app. | Behavioural | Female-Specific Cognitive Behavioral Therapy |
| Usual CareUsual care means that participants will receive brief alcohol counseling and have access to available treatments for AUD at the VA. | Behavioural | Female-Specific Cognitive Behavioral Therapy, Usual Care |
Primary outcome
Alcohol Use Disorders Identification Test (AUDIT)
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems
Structured Clinical Interview for DSM Disorders (SCID) Alcohol Use Disorder Module
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
semi-structured interview that assesses for alcohol use disorder based on the Diagnostic and Statistical Manual for Mental Disorders (DSM)
Form 90 Timeline Followback (TLFB)
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
interview used to assess alcohol and drug use over a specific period of time
Treatment Services Review (TSR)
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
interview used to assess use of Veterans Affairs and non-Veterans Affairs treatments including Alcohol Use Disorder treatment, physical and mental health treatment, and use of medications
Electronic Medical Record (EMR)
Time frame: assessed from baseline to 15-months post-baseline follow-up
patient's medical records - review to assess use of Veterans Affairs and non-Veterans Affairs treatments including Alcohol Use Disorder treatment, physical and mental health treatment, and use of medications
8 secondary outcomes
Outcome Questionnaire-45
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Posttraumatic Stress Disorder Checklist (PCL)-5 with Life Events Checklist (LEC)-5
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Difficulties in Emotion Regulation Scale (DERS)
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Coping Strategies Scale (CSS)
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Important People Interview (IPI)
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Sociotropy Autonomy Scale (SAS)
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Use of Women2Women mobile application
Time frame: assessed from baseline to 15-months post-baseline follow-up
Self-Care Questionnaire
Time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Alcohol Use Disorder
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
RecruitingPhase 1
Environment and Alcohol: A Pilot Study
Alcohol Use Disorder
RecruitingObservational study
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Alcoholism, Substance-Related Disorders
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Elizabeth E Epstein, PHD principal investigator
University of Massachusetts, Worcester
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Female-Specific Cognitive Behavioral Therapy (FS-CBT) in people with Alcohol Use Disorder and Risky Health Behavior, run by University of Massachusetts, Worcester at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Alcohol Use Disorders Identification Test (AUDIT) (time frame: assessed at baseline, and 3-, 9-, and 15-months post-baseline follow-up). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.